A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme

By Groves Morris   Puduvalli Vinay   Chang Susan   Conrad Charles   Gilbert Mark   Tremont-Lukats Ivo   Liu Ta-Jen   Peterson Pamela   Schiff David   Cloughesy Timothy   Wen Patrick   Greenberg Harry   Abrey Lauren   DeAngelis Lisa   Hess Kenneth   Lamborn Kathleen   Prados Michael   Yung W.  

Journal of Neuro-Oncology, Vol. 81, Iss. 3, 2007-02 ,pp. : 271-277

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II dose escalation trial of concurrent temozolomide and whole brain radiation therapy for multiple brain metastasis

By Mikkelsen Tom   Anderson Joe   Doyle Thomas   Croteau David   Avedissian Rita   Ryu Sam   Schultz Lonni  

Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. : 241-247

Springer Publishing Company

Access to resources Recommend Favorite

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

By Christodoulou Christos   Bafaloukos Dimitrios   Linardou Helen   Aravantinos Gerassimos   Bamias Aristotelis   Carina Maria   Klouvas George   Skarlos Dimosthenis  

Journal of Neuro-Oncology, Vol. 71, Iss. 1, 2005-01 ,pp. : 61-65

Springer Publishing Company

Access to resources Recommend Favorite

Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study

By                  

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 799-801

Spandidos Publications

Access to resources Recommend Favorite

Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian Cancer

By Burger R.A.   DiSaia P.J.   Roberts J.A.   O'Rourke M.   Gershenson D.M.   Homesley H.D.   Lichtman S.M.   Barnes W.   Moore D.H.   Monk B.J.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 148-153

Elsevier

Access to resources Recommend Favorite